Recommended Therapeutic INR Range for Patients with Antiphospholipid Syndrome on Warfarin Anticoagulation: Is Moderate-Intensity (INR 2.0 - 3.0) or High-Intensity (INR 3.1 - 4.0) Better for Reducing Risk of Recurrent Thromboembolic Events?
about
Recommended Therapeutic INR Range for Patients with Antiphospholipid Syndrome on Warfarin Anticoagulation: Is Moderate-Intensity (INR 2.0 - 3.0) or High-Intensity (INR 3.1 - 4.0) Better for Reducing Risk of Recurrent Thromboembolic Events?
description
2016 nî lūn-bûn
@nan
2016 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
name
Recommended Therapeutic INR Ra ...... current Thromboembolic Events?
@ast
Recommended Therapeutic INR Ra ...... current Thromboembolic Events?
@en
Recommended Therapeutic INR Ra ...... current Thromboembolic Events?
@nl
type
label
Recommended Therapeutic INR Ra ...... current Thromboembolic Events?
@ast
Recommended Therapeutic INR Ra ...... current Thromboembolic Events?
@en
Recommended Therapeutic INR Ra ...... current Thromboembolic Events?
@nl
prefLabel
Recommended Therapeutic INR Ra ...... current Thromboembolic Events?
@ast
Recommended Therapeutic INR Ra ...... current Thromboembolic Events?
@en
Recommended Therapeutic INR Ra ...... current Thromboembolic Events?
@nl
P2093
P2860
P3181
P356
P1433
P1476
Recommended Therapeutic INR Ra ...... current Thromboembolic Events?
@en
P2093
Esther Kim
Katie Peacock
Prisca T Takundwa
Tiffanie Do
P2860
P3181
P356
10.7759/CUREUS.765
P407
P577
2016-09-01T00:00:00Z